Background & Objectives: Volatile anaesthetics such as isoflurane, are associated with lower mortality and incidence of adverse myocardial events compared to total intravenous anaesthesia after cardiac surgery.(1) These cardioprotective outcomes are believed to be mediated by ischaemic preconditioning of myocardium. (2) To our knowledge, the myocardial isoflurane concentration in humans during cardiac surgery has never been measured. The high vascularity of myocardium enables myocardial isoflurane concentration to achieve equilibrium rapidly with its arterial blood.(3) Therefore, at equilibrium, venous level of isoflurane in the coronary sinus (CS) should reflect its myocardial concentration. The primary aim was to measure isoflurane concentration in CS blood. Secondary aims were to determine whether CS isoflurane concentrations had equilibrated with its arterial blood and could be estimated from oxygenator exhaust levels before the aortic cross-clamping (AXC) during cardiopulmonary bypass (CPB).
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Materials & Methods:
Nine patients undergoing cardiac surgery anaesthetised with isoflurane during CPB were enrolled in a prospective observational study. During CPB, isoflurane (1.0-2.5%) was administrated into the sweep gas to the oxygenator. Following the initiation of CPB and insertion of CS catheter but before the AXC, blood samples were collected from the CS and radial artery catheters, and were analysed for isoflurane with gas chromatography-mass spectrometry. The oxygenator exhaust isoflurane was measured continuously with an anaesthetic gas analyser and recorded at the time blood sampling.
Results:
The mean arterial and CS isoflurane concentration were 33.6μgmL -1 ±19.2 (mean±SD) and 26.8μgmL -1 ±15.6, respectively. There was a significant mean difference of 6.9μgmL -1 (95%CI:0.8,13.0) between CS and arterial isoflurane concentration. Oxygenator exhaust isoflurane levels were positively correlated with those in CS (r=0.75,ρ=0.020) and arterial blood (r=0.72,ρ=0.031). In a partial correlation analysis when controlled for covariates including haemoglobin concentration, mixed-venous temperature and sweep gas flow rate, the correlation coefficient between oxygenator exhaust isoflurane level and CS isoflurane concentration increased from r=0.75 to 0.92 (ρ=0.008).
Conclusion:
This pilot study reports measurements of isoflurane concentration in human CS blood. Their positive correlation suggests that monitoring the oxygenator exhaust isoflurane level may be an estimate of CS isoflurane concentration. Nevertheless, CS isoflurane concentration may not accurately represent those in the myocardium as both CS and arterial isoflurane had not equilibrated before the AXC during CPB.
